SecBot SecBot

COLL

COLLEGIUM PHARMACEUTICAL, INC
Nasdaq· Pharmaceutical Preparations· Inc. VA· CIK 0001267565 Biotech & Drug Discovery
$25.43 +0.11 (+0.43%)
Nov 16 4:00 PM ET · prev $25.32
Market cap
$775.3M
Small cap
Consensus
Buy
86% Buy or better · 14 analysts
Median target
$44.50
+75% · range $28.00–60.00
1 year
−43.9%
from $45.34 · Nov 17
30 days
+10.5%
from $23.01
52-week range
$21.53–49.84
−49% from high · low Oct 13
Avg volume 20D
625.8K
Nov 5 spike 1.57M
Short interest
5.19M
≈16.7% of shares · −3.4%
Days to cover
9.4
at average volume
Insider net
−$3.4M
0 buyers · 5 sellers · 12 mo
New fund stakes
0
Q3 2026 13F · 1 exit
Filing reports
20
analyzed by SecBot
SecBot read MIXED 13 reports · 90 days
Balance 2 bearish · 0 bullish · 2 mixed · 9 neutral oldest → newest, height = score
Avg score ·High conf. 10/13

Price

Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).

Signal stack

Where each data set points today.

  • InsidersBEARISH

    5 insiders sold $3.4M.

  • InstitutionsMIXED

    Q3 2026: 27 added (0 new), 28 trimmed or exited.

  • AnalystsBULLISH

    12 of 14 rate it Buy or better. Every target is above the price.

  • Short sellersSTEADY

    Short interest −3.4% to 5.19M shares. 9.4 days to cover, ≈16.7% of shares.

  • TrendUPTREND

    10% above its 50-day average.

Who's buying

13F· Q3 2026
0
new positions
1
exit
FundMoveSharesValue
Invesco Ltd.TRIM1,261,037$27.5M
AMERICAN CENTURY COMPANIES INCADD643,841$14.0M
FULLER & THALER ASSET MANAGEMENT, INC.TRIM598,540$13.1M
ROYCE & ASSOCIATES LPTRIM224,754$4.9M
FIRST TRUST ADVISORS LPADD223,608$4.9M
SEI INVESTMENTS COADD169,789$3.7M
PUBLIC SECTOR PENSION INVESTMENT BOARDTRIM110,770$2.4M
Creative PlanningDOUBLED101,648$2.2M

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

14 analysts
Buy 86% rate it Buy or better
Strong Buy5Buy7Hold2Sell0Strong Sell0
12-month targets · 8 analysts

Price is below the lowest target. Median implies +75%.Targets as of Nov 17, 2026.

Recent actions
DateFirmActionRating
Nov 16, 2026🔒 Fresh data, subscribers only
MAINTAIN
MAINTAIN
Nov 6, 2026Piper Sandler
MAINTAIN
MAINTAINNeutral
Nov 5, 2026Needham
MAINTAIN
MAINTAINBuy
Sep 23, 2026Oppenheimer
INITIATE
INITIATEOutperform
Sep 9, 2026Truist Securities
MAINTAIN
MAINTAINBuy
Sep 9, 2026Leerink Partners
INITIATE
INITIATEOutperform

Insider ledger

Form 4
$0
bought · 0 insiders
$3.4M
sold · 5 insiders
DateInsiderTypeValue
Jun 8, 2026
SANTINI GINO
Director
Jun 8, 2026
EXERCISE$143.5K
May 18, 2026
Freund John Gordon
Director
May 18, 2026
SELL$681.00
May 15, 2026
Freund John Gordon
Director
May 15, 2026
EXERCISE$143.5K
May 15, 2026
Freund John Gordon
Director
May 15, 2026
SELL$142.5K
May 14, 2026
Freund John Gordon
Director
May 14, 2026
AWARD8,741 sh
May 14, 2026
Glancy Donovan Michael
Director
May 14, 2026
AWARD17,482 sh
May 14, 2026
SANTINI GINO
Director
May 14, 2026
AWARD8,741 sh
May 14, 2026
Lurker Nancy
Director
May 14, 2026
AWARD8,741 sh

Earnings setup

Estimates

Revision history: 🔒 Fresh data, subscribers only

PeriodEPS est.Range30D rev.Revenue
Current Q🔒 Fresh data, subscribers only
Next Q🔒 Fresh data, subscribers only
Current FY🔒 Fresh data, subscribers only
Next FY🔒 Fresh data, subscribers only

Washington

Corporate Lobbying

18 lobbying filings and 0 bills this company lobbies on, with spend, stage and how each bill touches it, are for subscribers.

Subscribe for Full Access

Short side

FINRA· Oct 30, 2026
5,194,875
shares short
-3.4%
vs prior settlement
9.4
days to cover
≈16.7%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow, newest first.
Nov 16, 2026 SEC
🔒 Fresh report (last 24h), subscribers only
Nov 10, 2026 SEC
Invesco Ltd. filed an amended Schedule 13G disclosing a 3.9% passive stake in Collegium Pharmaceutical as of September…
SC 13G/A · Impact 4/10
Nov 10, 2026 SEC
State Street Corp filed a Schedule 13G disclosing a 5.4% passive stake in Collegium Pharmaceutical as of September 30…
SC 13G · Impact 3/10
Nov 5, 2026 Earnings
Collegium Reports Third Quarter 2026 Financial Results; Reaffirms 2026 Guidance
Generated Record Quarterly Net Revenues of $216.3 Million, Up 3% Year-over-Year
Oct 29, 2026 Press
Collegium Pharmaceutical announced an expanded multi-year partnership with Boston Legacy FC, a professional women's…
Impact 2/10
Sep 30, 2026 Inst.
Invesco Ltd. · TRIM
1,261,037 shares ($27.5M)
Sep 30, 2026 Inst.
AMERICAN CENTURY COMPANIES INC · ADD
643,841 shares ($14.0M)
Aug 19, 2026 Event
Walgreen Co. v. Collegium Pharmaceutical, Inc.
Court ruling (mad), Docket: 1:26-cv-11242
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
1 drug tracked · Drug pipeline →
Recent

SecBot reports

20 filings · 4 press releases · 2 bullish · 2 bearish · 3 mixed · 13 neutral
All COLL filing & press-release reports (24)